Key facts
- It has raised $327.9M across 5 recorded rounds; the latest was PIPE ($144.0M) in Feb 2025.
- 2 institutional filers report fund marks on Solid Biosciences across 6 filings.
- Solid Biosciences has filed 3 Form Ds with the SEC since 2019, most recently Dec 2022 ($9.2M sold to 13 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·Watchlist + deal alerts for Solid Biosciences
Create free account
No card required
Funding rounds
5 roundsFeb 2025PIPE$144.0M▮
Jan 2024PIPE$108.9M▮
Dec 2022PIPE$75.0M▮
About Solid Biosciences
- Industry
- Drug Discovery
PA Mark — not yet priced
Solid Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Solid Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
2 filers · latest May 20262 SEC-registered funds reported 6 fair-value marks on Solid Biosciences between May 2025 and May 2026. Filer-level marks and implied $/share are available to Pro members.